All Type of News
Upward momentum of pharmaceutical firms shares likely to continue in April
Market analysts say that with increasing optimism on the possible commercialization of new drugs, combined with a foreign investors' buying spree, the index of pharmaceutical firms rose 3.07 percent in Februar...
Controlled drug packages discordant to label claims.
Some psychotropic control drugs in the retail pharmacies revealed that the package did not contain number of tablets as labelled or contained broken tablets, causing many troubles in keeping correct records in complia...
Some drug company stocks rising due to SARS.
Amid a global panic with SARS breakout from the Southern China and the rumor that the plague also already landed in Korea, acute fears rapidly spreaded across the whole nation, in the meanwhile, causing some drug comp...
Ezmedicom tries to convince wholesalers
With reference to the wholesaling industry's mounting suspicion on a private agreement between Ezmedicom and Seoul National University Hospital for the exclusive bidding business, Ezmedicom has maintained that such ag...
EUCCK urges Korean government to create A7 pricing for innovative new products
The European Union Chamber of Commerce in Korea (EUCCK) called on the Korean government to revamp its pharmaceutical reimbursement system including drug-related policies, according to a report.
During the EUCCK-org...
Robust 2002 sales seen in foreign-invested pharmaceutical firms
Despite initial perspective that the domestic pharmaceutical industry would suffer a serious setback in its projected turnover and growth last year, the majority of foreign-invested pharmaceutical firms fared well in ...
HIRA mulls review guideline over 8 cold related diseases.
The Health Insurance Review Agency (HIRA) has prepared a review guideline over cold related and acute respiratory infections, which occupied by about 26% of the total national insurance coverage, possibly provoking se...
KFDA approved second indication for Cozaar.
The KFDA approved Cozaar, an anti-hypertensive drug (Losartan K) of MSD Korea for the treatment of renopathy complicated with the type 2 diabetic patient as the 2nd indication.
The KFDA's approval was based on the ...
KFDA to root out illegal drug sales through internet.
The KFDA announced to intensify far strict inspections over the false and exaggerative advertising activities as well as the illegal sales of drugs, cosmetics and medical devices through the internet shopping malls, T...
Government urged to promote prescription by generic name
Dr. Cho Jae-kook, a chief fellow from the Korea Institute of Health and Social Affairs, said in a recent symposium that the following issues should be addressed for more efficient operation on the ongoing system of se...
